Hill-Rom Selects NanoHorizons to Provide Antimicrobial Protection for Hill-Rom Products Using Nanotechnology
06 Mars 2008 - 3:00PM
PR Newswire (US)
New relationship between NanoHorizons and Hill-Rom delivers patient
support systems enhanced with revolutionary antimicrobial
technology BATESVILLE, Ind., March 6 /PRNewswire-FirstCall/ --
Hill-Rom and NanoHorizons, Inc. today announced an agreement to
incorporate NanoHorizon's antimicrobial technology into Hill-Rom's
patient support surfaces. This technology, to be branded as
"nanoAg+ (TM) with SmartSilver(TM)", will bring new levels of
protection against institutionally-borne pathogens. Hill-Rom, the
medical technology subsidiary of Hillenbrand Industries, Inc.
(NYSE:HB), is a leading worldwide manufacturer and provider of
medical technologies and related services for the health care
industry. NanoHorizons, a leader in the field of advanced
nanomaterials, engineers and delivers permanent antimicrobial
solutions under the SmartSilver(TM) brand. "Our relationship with
NanoHorizons is a natural next step in Hill-Rom's commitment to
leveraging and integrating differentiated external technologies to
help deliver enhanced outcomes for patients and their caregivers,"
said Peter Soderberg, president and CEO of Hillenbrand Industries
and Hill-Rom. "Caregivers and health care administrators are
looking for solutions on how they can prevent health
care-associated infections. We anticipate that our relationship
with NanoHorizons will yield a comprehensive portfolio of products
with built-in, long-lasting antimicrobial protection. Given how
important this issue is for the health care industry, we aim to
offer a nanoAg+ with SmartSilver option on all of our preventative
and therapeutic surface products by the end of 2009." Infection
control is one of the critical issues in health care today. In its
2003 Guidelines for Environmental Infection Control in Health Care
Facilities, the Centers for Disease Control and Prevention (CDC)
has identified that, "Contaminated textiles and fabrics often
contain high numbers of microorganisms from body substances,
including blood, skin, stool, urine, vomitus, and other body
tissues and fluids."(1) Further, the CDC estimates that health
care-associated infections account for an estimated 1.7 million
infections and 99,000 associated deaths each year in US
hospitals.(2) Silver is one of nature's most powerful antimicrobial
agents. In lab tests, it has been found to be 99.9 percent
effective in the reduction of surface bacteria and viruses
including the virulent staph infection known as
Methicillin-resistant Staphylococcus aureus (MRSA). Unlocking
silver's properties for use as a protector is a specialized
scientific field, an area where NanoHorizons scientists have been
leaders. Unlike other silver technologies being offered today,
NanoHorizons has pioneered the specific use of nanotechnology to
create and manipulate materials that are smaller than 100
nanometers in size. When applied to coatings, fabrics and
laminates, nanotechnology allows the silver to cover an area more
effectively and last much longer than any other antimicrobial
coating, according to Dr. Stephen Fonash, Kunkle Chair of
Engineering Science at Penn State University and Co- Founder of
NanoHorizons. To bring the enhanced benefits of SmartSilver into
the hospital and other caregiver settings through application to
beds and therapeutic surfaces requires the special expertise of
Hill-Rom working with NanoHorizons to create nanoAg+(TM). Together,
these two companies will soon introduce nanoAg+ with SmartSilver, a
vital new solution for the health care environment. "The
SmartSilver brand is succeeding in a wide variety of fields with
partners who share a common interest in delivering leading-edge
antimicrobial product protection to today's marketplace," said
Daniel Hayes, president and chief executive officer of
NanoHorizons. "Hill-Rom is an ideal partner for advanced medical
equipment applications, given their longstanding commitment to
innovation and their unwavering dedication to improved patient
outcomes." ABOUT NANOHORIZONS, INC. NanoHorizons, Inc.,
(http://www.nanohorizons.com/) with its solid foundation in applied
chemistry and engineering, is a leader in the emerging field of
practical nanotechnology. NanoHorizon's SmartSilver(TM)
antimicrobial offers permanent bacterial control for textiles,
medical devices and industrial materials. NanoHorizons is privately
held and headquartered in State College, PA. The company works
closely with customers from its R&D laboratory, manufacturing
facility, and technical support office adjacent to The Penn State
University. ABOUT HILL-ROM. Hill-Rom, an operating company of
Hillenbrand Industries, Inc., is a leading worldwide manufacturer
and provider of medical technologies and related services for the
health care industry, including patient support systems,
non-invasive therapeutic products for a variety of acute and
chronic medical conditions, medical equipment rentals, and workflow
information technology solutions. Hill-Rom's comprehensive product
and service offerings are used by health care providers across the
health care continuum in hospitals, extended care facilities and
home care settings to enhance the safety and quality of patient
care. Hill-Rom... enhancing outcomes for patients and their
caregivers. Hillenbrand Disclosure Regarding Forward-Looking
Statements Certain statements in this press release contain
forward-looking statements, within the meaning of the Private
Securities Litigation Reform Act of 1995, regarding the Company's
future plans, objectives, beliefs, expectations, representations
and projections. The Company has tried, wherever possible, to
identify these forward-looking statements using words such as
"intend," "anticipate," "believe," "plan," "encourage," "expect,"
"may," "goal," "become," "pursue," "estimate," "strategy," "will,"
"projection," "forecast," "continue," "accelerate," "promise,"
"increase," "higher," "lower," "reduce," "improve," "expand,"
"progress," "potential" or the negative of those terms or other
variations of them or by comparable terminology. The absence of
such terms, however, does not mean that the statement is not
forward-looking. It is important to note that forward- looking
statements are not guarantees of future performance, and the
Company's actual results could differ materially from those set
forth in any forward- looking statements. Factors that could cause
actual results to differ from forward-looking statements include
but are not limited to: the Company's dependence on its
relationships with several large national providers and group
purchasing organizations, changes in death rates, whether the
Company's new products are successful in the marketplace, changes
in customers' Medicare reimbursements, collections of accounts
receivable, compliance with FDA regulations, antitrust litigation,
potential exposure to product liability or other claims, failure of
the Company's announced strategic initiatives and restructuring and
realignment activities to achieve expected growth, efficiencies or
cost reductions, disruptions in the Company's business or other
adverse consequences resulting from the planned separation of the
Company's two operating companies, failure of the Company to
execute its acquisition and business alliance strategy through the
consummation and successful integration of acquisitions or entry
into joint ventures or other business alliances, competition from
nontraditional sources in the funeral services business, volatility
of the Company's investment portfolio, increased costs or
unavailability of raw materials, labor disruptions, the ability to
retain executive officers and other key personnel, and certain
tax-related matters. For a more in depth discussion of these and
other factors that could cause actual results to differ from those
contained in forward-looking statements, see the discussions under
the heading "Risk Factors" in the Company's Annual Report on Form
10-K for the period ended September 30, 2007 and in Amendment 1 to
the Batesville Holdings, Inc., Form 10. The Company assumes no
obligation to update or revise any forward-looking statements. (1)
http://www.cdc.gov/ncidod/dhqp/pdf/guidelines/Enviro_guide_03.pdf
(2) http://www.cdc.gov/ncidod/dhqp/hai.html Hill-Rom Media: Lauren
Green-Caldwell, Director, Corporate Communications & Public
Relations Phone: 812-934-8692 Email: Hill-Rom Investor Relations:
Blair A. (Andy) Rieth, Jr., Vice President, Investor Relations,
Corporate Communications & Global Brand Development,
Hillenbrand Industries, Inc. Phone: 812-931-2199 Email: DATASOURCE:
Hillenbrand Industries, Inc. CONTACT: Media, Lauren Green-Caldwell,
Director, Corporate Communications & Public Relations,
+1-812-934-8692, lauren.green- ; or Investor Relations, Blair A.
(Andy) Rieth, Jr., Vice President, Investor Relations, Corporate
Communications & Global Brand Development, +1-812-931-2199, ,
both of Hillenbrand Industries, Inc. Web site:
http://www.hill-rom.com/ http://www.nanohorizons.com/
Copyright
Hillenbrand (NYSE:HB)
Graphique Historique de l'Action
De Juin 2024 à Juil 2024
Hillenbrand (NYSE:HB)
Graphique Historique de l'Action
De Juil 2023 à Juil 2024